Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review

September 2021 | 47 pages | ID: HD5C4535C14EN
GlobalData

Abstracts

Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hanmi Pharmaceuticals Co Ltd (Hanmi Pharmaceuticals), a subsidiary of Hanmi Science Co Ltd, develops prescription drugs and over the counter (OTC) drugs. The company’s prescription drugs include antibiotics, antidiarrheal, osteoporosis, liver supplements and antiemetics. It provides OTC products such as nutritional supplements, calcium supplement, vitamins, among others. Hanmi Pharmaceuticals' products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others. The company operates through its manufacturing facilities located in Hwaseong, Songpa and Pyeongtaek, South Korea. Hanmi Pharmaceuticals is headquartered in Seoul, South Korea.

Hanmi Pharmaceuticals Co Ltd Key Recent Developments

Jul 01,2021: Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology
Feb 12,2021: Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines
Jan 18,2021: Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
Jan 12,2021: Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine)
Aug 04,2020: Merck licences NASH drug efinopegdutide from Hanmi

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Hanmi Pharmaceuticals Co Ltd - Key Facts
Hanmi Pharmaceuticals Co Ltd - Key Employees
Hanmi Pharmaceuticals Co Ltd - Key Employee Biographies
Hanmi Pharmaceuticals Co Ltd - Major Products and Services
Hanmi Pharmaceuticals Co Ltd - History
Hanmi Pharmaceuticals Co Ltd - Company Statement
Hanmi Pharmaceuticals Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Hanmi Pharmaceuticals Co Ltd - Business Description
Product Category: Licensing Royalties
Performance
Product Category: Other Sales
Performance
Product Category: Beijing Hanmi
Overview
Performance
Key Stats
Product Category: Hanmi Fine Chem
Overview
Performance
Product Category: Hanmi Pharm
Overview
Performance
R&D Overview
Hanmi Pharmaceuticals Co Ltd - Corporate Strategy
Hanmi Pharmaceuticals Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Hanmi Pharmaceuticals Co Ltd - Strengths
Hanmi Pharmaceuticals Co Ltd - Weaknesses
Hanmi Pharmaceuticals Co Ltd - Opportunities
Hanmi Pharmaceuticals Co Ltd - Threats
Hanmi Pharmaceuticals Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 01, 2021: Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology
Feb 12, 2021: Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines
Jan 18, 2021: Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
Jan 12, 2021: Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine)
Aug 04, 2020: Merck licences NASH drug efinopegdutide from Hanmi
Jan 15, 2020: Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is 'ready to lead global pharmaceutical market with innovative R&D pipeline'

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Hanmi Pharmaceuticals Co Ltd, Key Facts
Hanmi Pharmaceuticals Co Ltd, Key Employees
Hanmi Pharmaceuticals Co Ltd, Key Employee Biographies
Hanmi Pharmaceuticals Co Ltd, Major Products and Services
Hanmi Pharmaceuticals Co Ltd, History
Hanmi Pharmaceuticals Co Ltd, Other Locations
Hanmi Pharmaceuticals Co Ltd, Subsidiaries
Hanmi Pharmaceuticals Co Ltd, Key Competitors
Hanmi Pharmaceuticals Co Ltd, Ratios based on current share price
Hanmi Pharmaceuticals Co Ltd, Annual Ratios
Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...1)
Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...2)
Hanmi Pharmaceuticals Co Ltd, Interim Ratios
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Hanmi Pharmaceuticals Co Ltd, Performance Chart (2016 - 2020)
Hanmi Pharmaceuticals Co Ltd, Ratio Charts
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021